TGFβ1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: The role of Smad2/3

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 846-854

  Ge, Qi ^a,b   Moir, Lyn M ^a,b   Black, Judith L ^a,b,c   Oliver, Brian G ^a,b,c   Burgess, Janette K ^a,b,c  

^a University of Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CRC for Asthma and Airways   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADOLESCENT; BINDING SITE; BRONCHUS; CASE CONTROL STUDY; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT MUCOSA; UPREGULATION;

ADOLESCENT; ADULT; AGED; ASTHMA; BINDING SITES; BLOTTING, WESTERN; BRONCHI; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MIDDLE AGED; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; RESPIRATORY MUCOSA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; YOUNG ADULT;

EID: 77957745748     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22295     Document Type: Article

References (42)

1. Adachi Y, Mio T, Takigawa K, Striz I, Romberger DJ, Robbins RA, Spurzem JR, Heires P, Rennard SI. 1997. Mutual inhibition by TGF-beta and IL-4 in cultured human bronchial epithelial cells. Am J Physiol 273: L701-L708.
2. Ashburner BP, Westerheide SD, Baldwin AS, Jr. 2001. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065-7077.
3. Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, Zangrilli JG, Peters SP. 2004. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34: 437-444.
4. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: Implications for cystic fibrosis. Am J Respir Cell Mol Biol 9: 455-462.
5. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161: 1720-1745.
6. Boxall C, Holgate ST, Davies DE. 2006. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 27: 208-229.
7. Burgess JK, Carlin S, Pack RA, Arndt GM, Au WW, Johnson PR, Black JL, Hunt NH. 2004. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: A possible role in asthma? J Allergy Clin Immunol 113: 683-689.
8. Burgess JK, Oliver BG, Poniris MH, Ge Q, Boustany S, Cox N, Moir LM, Johnson PR, Black JL. 2006. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol 118: 649-657.
9. Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel PY, Siegmund K, Meyer N, Akdis CA, Schmidt-Weber CB. 2009. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 123: 588-595. 595. e1-7.
10. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278: 17036-17043.
11. Cruse G, Cockerill S, Bradding P. 2008. IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol 9: 2.
12. Elias JA. 2000. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 161: S168-S171.
13. Fong CY, Pang L, Holland E, Knox AJ. 2000. TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279: L201-L207.
14. Gibson PG, Wark PA, Simpson JL, Meldrum C, Meldrum S, Saltos N, Boyle M. 2003. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 21: 582-588.
15. Goulet S, Bihl MP, Gambazzi F, Tamm M, Roth M. 2007. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts. J Cell Physiol 210: 167-176.
16. Griego SD, Weston CB, Adams JL, Tal-Singer R, Dillon SB. 2000. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 165: 5211-5220.
17. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick SM, Bai TR, Knight DA. 2009. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med 180: 122-133.
18. Halder SK, Beauchamp RD, Datta PK. 2005. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7: 509-521.
19. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang XF, Rich JN. 2004. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3: 737-745.
20. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.
21. Ip WK, Wong CK, Lam CW. 2006. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: Involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 145: 162-172.
22. Jagels MA, Hugli TE. 2000. Mixed effects of TGF-beta on human airway epithelial-cell chemokine responses. Immunopharmacology 48: 17-26.
23. Johnson PR, Burgess JK, Ge Q, Poniris M, Boustany S, Twigg SM, Black JL. 2006. Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med 173: 32-41.
24. Kelley TJ, Elmer HL, Corey DA. 2001. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 25: 732-738.
25. Kicic A, Sutanto EN, Stevens PT, Knight DA, Stick SM. 2006. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am J Respir Crit Care Med 174: 1110-1118.
26. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, Tonnel AB. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 157: 394-402.
27. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA. 2002. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64.
28. Makinde T, Murphy RF, Agrawal DK. 2007. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol 85: 348-356.
29. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ. 1997. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J 321: 639-643.
30. Murphy DM, Forrest IA, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Ward C, Lordan JL. 2008. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. Am J Physiol Lung Cell Mol Physiol 294: L592-L599.
31. Pelaia G, Cuda G, Vatrella A, Fratto D, Grembiale RD, Tagliaferri P, Maselli R, Costanzo FS, Marsico SA. 2003. Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. Am J Respir Cell Mol Biol 29: 12-18.
32. Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. 2004. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 31: 626-632.
33. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. 1997. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 156: 642-647.
34. Semlali A, Jacques E, Plante S, Biardel S, Milot J, Laviolette M, Boulet LP, Chakir J. 2008. TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells. Am J Respir Cell Mol Biol 38: 202-208.
35. Shinkai M, Foster GH, Rubin BK. 2006. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L75-L85.
36. Takizawa H. 1998. Airway epithelial cells as regulators of airway inflammation (Review). Int J Mol Med 1: 367-378.
37. Takizawa H, Ohtoshi T, Yamashita N, Oka T, Ito K. 1996. Interleukin 6-receptor expression on human bronchial epithelial cells: Regulation by IL-1 and IL-6. Am J Physiol 270: L346-L352.
38. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. 2007. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 179: 5483-5492.
39. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. 1999. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 159: 487-494.
40. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. 2005. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16: 1987-2002.
41. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. 1997. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 156: 591-599.
42. Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M. 2006. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: A comparison between mesothelioma and mesothelial cells. J Cell Physiol 207: 540-552.